MicrobiologybioRxiv
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice
J. H. Jeong, S. Chokkakula, S. C. Min…·M.-S. Song
This paper evaluates combination antiviral therapies in SARS-CoV-2 infected mice, finding that nirmatrelvir and molnupiravir together significantly improve survival compared to monotherapies.
DOI 10.1016/j.antiviral.2022.105430